A study evaluating effect of febuxostat on insulin resistance and the expression of high-sensitivity C-reactive protein (hs-CRP) in patients with primary gout.
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Pharmacodynamics; Therapeutic Use
- 04 Sep 2017 New trial record